IBDEI2FE ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,41147,2)
 ;;=^5019598
 ;;^UTILITY(U,$J,358.3,41148,0)
 ;;=R80.3^^159^2000^84
 ;;^UTILITY(U,$J,358.3,41148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41148,1,3,0)
 ;;=3^Proteinuria Bence Jones
 ;;^UTILITY(U,$J,358.3,41148,1,4,0)
 ;;=4^R80.3
 ;;^UTILITY(U,$J,358.3,41148,2)
 ;;=^13272
 ;;^UTILITY(U,$J,358.3,41149,0)
 ;;=R80.9^^159^2000^89
 ;;^UTILITY(U,$J,358.3,41149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41149,1,3,0)
 ;;=3^Proteinuria,Unspec
 ;;^UTILITY(U,$J,358.3,41149,1,4,0)
 ;;=4^R80.9
 ;;^UTILITY(U,$J,358.3,41149,2)
 ;;=^5019599
 ;;^UTILITY(U,$J,358.3,41150,0)
 ;;=Z87.442^^159^2000^77
 ;;^UTILITY(U,$J,358.3,41150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41150,1,3,0)
 ;;=3^Personal Hx of Urinary Calculi
 ;;^UTILITY(U,$J,358.3,41150,1,4,0)
 ;;=4^Z87.442
 ;;^UTILITY(U,$J,358.3,41150,2)
 ;;=^5063497
 ;;^UTILITY(U,$J,358.3,41151,0)
 ;;=N18.1^^159^2000^13
 ;;^UTILITY(U,$J,358.3,41151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41151,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 1
 ;;^UTILITY(U,$J,358.3,41151,1,4,0)
 ;;=4^N18.1
 ;;^UTILITY(U,$J,358.3,41151,2)
 ;;=^5015602
 ;;^UTILITY(U,$J,358.3,41152,0)
 ;;=N18.2^^159^2000^14
 ;;^UTILITY(U,$J,358.3,41152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41152,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 2
 ;;^UTILITY(U,$J,358.3,41152,1,4,0)
 ;;=4^N18.2
 ;;^UTILITY(U,$J,358.3,41152,2)
 ;;=^5015603
 ;;^UTILITY(U,$J,358.3,41153,0)
 ;;=N18.3^^159^2000^15
 ;;^UTILITY(U,$J,358.3,41153,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41153,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 3
 ;;^UTILITY(U,$J,358.3,41153,1,4,0)
 ;;=4^N18.3
 ;;^UTILITY(U,$J,358.3,41153,2)
 ;;=^5015604
 ;;^UTILITY(U,$J,358.3,41154,0)
 ;;=N18.4^^159^2000^16
 ;;^UTILITY(U,$J,358.3,41154,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41154,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 4
 ;;^UTILITY(U,$J,358.3,41154,1,4,0)
 ;;=4^N18.4
 ;;^UTILITY(U,$J,358.3,41154,2)
 ;;=^5015605
 ;;^UTILITY(U,$J,358.3,41155,0)
 ;;=N18.5^^159^2000^17
 ;;^UTILITY(U,$J,358.3,41155,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41155,1,3,0)
 ;;=3^Chronic Kidney Disease,Stage 5
 ;;^UTILITY(U,$J,358.3,41155,1,4,0)
 ;;=4^N18.5
 ;;^UTILITY(U,$J,358.3,41155,2)
 ;;=^5015606
 ;;^UTILITY(U,$J,358.3,41156,0)
 ;;=Q61.3^^159^2000^80
 ;;^UTILITY(U,$J,358.3,41156,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41156,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,41156,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,41156,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,41157,0)
 ;;=N20.1^^159^2000^9
 ;;^UTILITY(U,$J,358.3,41157,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41157,1,3,0)
 ;;=3^Calculus Ureter
 ;;^UTILITY(U,$J,358.3,41157,1,4,0)
 ;;=4^N20.1
 ;;^UTILITY(U,$J,358.3,41157,2)
 ;;=^5015608
 ;;^UTILITY(U,$J,358.3,41158,0)
 ;;=N18.9^^159^2000^18
 ;;^UTILITY(U,$J,358.3,41158,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41158,1,3,0)
 ;;=3^Chronic Kidney Failure,Unspec
 ;;^UTILITY(U,$J,358.3,41158,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,41158,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,41159,0)
 ;;=N18.6^^159^2000^28
 ;;^UTILITY(U,$J,358.3,41159,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41159,1,3,0)
 ;;=3^End Stage Renal Disease (ESRD)
 ;;^UTILITY(U,$J,358.3,41159,1,4,0)
 ;;=4^N18.6
 ;;^UTILITY(U,$J,358.3,41159,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,41160,0)
 ;;=N52.9^^159^2000^44
 ;;^UTILITY(U,$J,358.3,41160,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,41160,1,3,0)
 ;;=3^Erectile Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,41160,1,4,0)
 ;;=4^N52.9
 ;;^UTILITY(U,$J,358.3,41160,2)
 ;;=^5015763
 ;;^UTILITY(U,$J,358.3,41161,0)
 ;;=N32.81^^159^2000^75
